Meyka Pro banner
Pro-Dex, Inc.

Pro-Dex, Inc. (PDEX) Stock Overview

Explore Pro-Dex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PDEXNASDAQ
HealthcareMedical - Instruments & Supplies
$54.93
$0.26(0.48%)
U.S. Market opens in 14h 27m

Pro-Dex, Inc. (PDEX)

Meyka AI Score

Z

Key Financials

Market Cap175.4M
P/E Ratio15.02
EPS (TTM)$2.84
ROE0.29%
Fundamental Analysis

AI Price Forecasts

1 Month$44.61
3 Months$37.24
1 Year Target$61.49

PDEX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pro-Dex, Inc. (NASDAQ: PDEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Pro-Dex, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PDEX on the NASDAQ shows an RSI of 41.45, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $61.49 for the NASDAQ listing.

Key metrics behind Pro-Dex, Inc.'s NASDAQ-traded stock include a P/E ratio of 15.02 and a market capitalization of 175.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PDEX on the NASDAQ.

Price Performance (NASDAQ: PDEX)

1-Day Change
0.48%
5-Day Change
-6.20%
1-Month Change
-15.13%
3-Month Change
5.43%
6-Month Change
40.41%
Year-to-Date (YTD) Change
42.75%
1-Year Change
10.26%
3-Year Change
193.84%
5-Year Change
85.45%
All-Time (Max) Change
240.55%

Contact Information

949 769 3200
2361 McGaw Avenue, Irvine, CA, 92614

Company Facts

1,810 Employees
IPO DateAug 7, 1986
CountryUS
Actively Trading

Frequently Asked Questions